MediWound (MDWD) Interest Expenses (2013 - 2026)
MediWound (MDWD) posted quarterly Interest Expenses of -$8.0 million for Q2 2025, down 232.35% year-over-year from $6.0 million in Q2 2024, and down 232.35% quarter-over-quarter from -$2.4 million in Q2 2024.
MediWound (MDWD) Interest Expenses (2013 - 2026) Analysis & Trends
MediWound's Interest Expenses history runs 13 years deep, the most recent figure standing at -$8.0 million for Q2 2025.
- In Q2 2025, Interest Expenses fell 232.35% year-over-year to -$8.0 million; the TTM figure through Dec 2025 stood at -$8.0 million (down 232.35% YoY), while the FY2025 annual figure was $2.5 million, down 80.79% from the prior year.
- Interest Expenses for Q2 2025 stood at -$8.0 million, down from -$2.4 million in the prior quarter.
- The five-year high for Interest Expenses was $4.0 million in Q4 2021, with the low at -$8.0 million in Q2 2025.
- The 5-year median for Interest Expenses is -$448500.0 (2021), against an average of -$625714.3.
- The sharpest annual moves came in 2021 and 2025: Interest Expenses jumped 7633.96% in 2021, then slumped 232.35% in 2025.
- MediWound's Interest Expenses stood at $4.0 million in 2021, then plunged by 110.22% to -$408000.0 in 2022, then surged by 905.64% to $3.3 million in 2023, then tumbled by 173.17% to -$2.4 million in 2024, then plunged by 232.35% to -$8.0 million in 2025.
- Business Quant data shows MDWD's Interest Expenses at -$8.0 million in Q2 2025, -$2.4 million in Q2 2024, and $3.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Jun 30, 2026 | 1.12 Mn |
| Jun 30, 2025 | -7.99 Mn |
| Jun 30, 2025 | -7.99 Mn |
| Jun 30, 2024 | -2.41 Mn |
| Jun 30, 2024 | -2.41 Mn |
| Dec 31, 2023 | 3.29 Mn |
| Dec 31, 2023 | 3.29 Mn |
| Sep 30, 2023 | -390,000.00 |
| Sep 30, 2023 | -390,000.00 |
| Jun 30, 2023 | -893,000.00 |
| Jun 30, 2023 | -893,000.00 |
| Mar 31, 2023 | -246,000.00 |
| Mar 31, 2023 | -246,000.00 |
| Dec 31, 2022 | -408,000.00 |
| Dec 31, 2022 | -408,000.00 |
| Sep 30, 2022 | -781,000.00 |
| Sep 30, 2022 | -781,000.00 |
| Jun 30, 2022 | -687,000.00 |
| Jun 30, 2022 | -687,000.00 |